Solubility and dissolution rate enhancement of lumefantrine using hot melt extrusion technology with physicochemical characterisation

Journal of Pharmaceutical Investigation

Volumn 43, Issue 4, 2013, Pages 305-321

  Fule, Ritesh ^a   Meer, Tariq ^a   Sav, Ajay ^a   Amin, Purnima ^a  

^a INSTITUTE OF CHEMICAL TECHNOLOGY   (India)

Author keywords

Dissolution rate; Hot melt extrusion; Lumefantrine; Solid dispersion; Solubility

Indexed keywords

BENFLUMETOL; POVIDONE;

ANTIMALARIAL ACTIVITY; ARTICLE; DRUG MANUFACTURE; DRUG SCREENING; DRUG SOLUBILITY; DRUG STABILITY; FOURIER TRANSFORM INFRARED PHOTOACOUSTIC SPECTROSCOPY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HOT MELT EXTRUSION; MOISTURE; MOLECULAR INTERACTION; MOLECULAR MODEL; PARASITE VIABILITY; PHYSICAL CHEMISTRY; POWDER FLOW; PRIORITY JOURNAL; SCANNING ELECTRON MICROSCOPY; STANDARDIZATION; ULTRAVIOLET SPECTROSCOPY; X RAY POWDER DIFFRACTION;

EID: 84880692410     PISSN: 20935552     EISSN: 20936214     Source Type: Journal    
DOI: 10.1007/s40005-013-0078-z     Document Type: Article

References (30)

1. Almeida A, Possemiers S (2011) Ethylene vinyl acetate as matrix for oral sustained release dosage forms produced via hot-melt extrusion. Eur J Pharm Biopharm 77(2): 297-305.
2. Ambike AA, Mahadik KR, Paradkar A (2004) Stability study of amorphous valdecoxib. Int J Pharm 282: 151-162.
3. Andriantsoanirina V (2011) Resistance of Plasmodium falciparum to antimalarial drugs: impact on malaria pre-elimination in Madagascar. Med Trop Mars 1: 298-304.
4. Bacon DJ, Latour C, Picot S (2007) Comparison of a SYBR green i-based assay with a histidine-rich protein ii enzyme-linked immunosorbent assay for in vitro antimalarial drug efficacy testing and application to clinical isolates. Antimicrob Agents Chemother 51: 1172-1178.
5. Breitenbach J (2002) Melt extrusion: from process to drug delivery technology. Eur J Pharm Biopharm 54: 107-117.
6. Chiou WL, Riegelman S (1971) Pharmaceutical applications of solid dispersion systems. J Pharm Sci 60: 1281-1302.
7. Chokshi RJ, Zia H, Sandhu HK, Shah NH, Malick WA (2007) Improving the dissolution rate of poorly water soluble drug by solid dispersion and solid solution. Drug Deliv 14(1): 33-45.
8. Crowley MM, Zhang F, Koleng JJ, McGinity JW (2002) Stability of polyethylene oxide in matrix tablets prepared by hot-melt extrusion. Biomaterials 23: 4241-4248.
9. Doshi DH, Betageri GV (1997) Carbamazepine and polyethylene glycol solid dispersion preparation, in vitro dissolution, and characterization. Drug Dev Ind Pharm 23: 1167-1176.
10. Ford JL (1986) The current status of solid dispersions. Pharm Acta Helvetica 61: 69-88.
11. Gahoia S, Jain GK (2012) Enhanced antimalarial activity of lumefantrine nanopowder prepared by wet-milling DYNO MILL technique. Colloids Surf B Biointerfaces. doi: 10. 1016/j. colsurfb. 2012. 01. 047.
12. Gavin PA, Osama AD (2010) Physicochemical characterization and drug-release properties of celecoxib hot-melt extruded glass solutions. J Pharm Pharmacol 62: 1580-1590.
13. Greenhalgh DJ, Timmins PY (1999) Solubility parameters as predictors of miscibility in solid dispersions. J Pharm Sci 88: 1182-1190.
14. Hancock BC, Zografi G (1997) Characteristics and significance of the amorphous state in pharmaceutical systems. J Pharm Sci 86: 1-12.
15. Higuchi T, Connors K (1965) Phase-solubility techniques. Adv Anal Chem Inst Technol 4: 117-130.
16. Juma E (2008) A randomized, open-label, comparative efficacy trial of artemether-lumefantrine suspension versus artemether-lumefantrine tablets for treatment of uncomplicated Plasmodium falciparum malaria in children in western Kenya. Malar J 7: 262-280.
17. Kalogeras IM (2011) A novel approach for analyzing glass-transition temperature vs. composition patterns: application to pharmaceutical compound+polymer systems. Eur J Pharm Sci 42: 470-483.
18. Konno H, Taylor LS (2006) Influence of different polymers on the crystallization tendency of molecularly dispersed amorphous felodipine. J Pharm Sci 95: 2692-2705.
19. Linn M (2012) Soluplus as an effective absorption enhancer of poorly soluble drugs in vitro. Eur J Pharm Sci 45: 336-343.
20. Makar RR, Latif R, Hosni EA, Omaima N, Gazayerly El (2013) Optimization for glimepiride dissolution enhancement utilizing different carriers and techniques. J Pharm Invest 43: 115-131.
21. Maniruzzaman M, Morgan DJ, Douroumis D (2013) Drug-polymer intermolecular interactions in hot-melt extruded solid dispersions. Int J Pharm 443: 199-208.
22. McGinity JW, Zhang F, Repka MA, Koleng JJ (2001) Hot-melt extrusion as a pharmaceutical process. Am Pharm Rev 4(2): 25-36.
23. Osama AA, David SJ (2012) Understanding the performance of melt-extruded poly(ethylene oxide)-bicalutamide solid dispersions: characterisation of microstructural properties using thermal, spectroscopic and drug release methods. J Pharm Sci 101: 200-213.
24. Rasenack N, Muller B (2002) Development of novel ibuprofen-loaded solid dispersion with improved bioavailability using aqueous solution. Arch Pharm Res 19: 1894-1903.
25. Repka MA, Prodduturi S, Stodghill SP (2003) Production and characterization of hot-melt extruded films containing clotrimazole. Drug Dev Ind Pharm 29: 757-765.
26. Suneela P (2005) Solid-state stability and characterization of hot-melt extruded poly(ethylene oxide) films. J Pharm Sci 94: 2232-2245.
27. Takeuchi H, Nagira S (2004) Solid dispersion particles of tolbutamide prepared with fine silica particles by the spray-drying method. Powder Technol 141: 187-195.
28. Vasconcelos T, Sarmento B, Costa P (2007) Solid dispersions as strategy to improve oral bioavailability of poor water soluble drugs. Drug Disc Today 12: 1068-1075.
29. Zhang F, McGinity JW (1999) Properties of sustained- release tablets prepared by hot-melt extrusion. Pharm Dev Technol 4: 241-250.
30. Zsombor KN, Attila B (2012) Comparison of electrospun and extruded Soluplus -based solid dosage forms of improved dissolution. J Pharm Sci 101: 322-332.